Stratos Wealth Advisors LLC Cuts Stake in Colgate-Palmolive (NYSE:CL)

Stratos Wealth Advisors LLC lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 18.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 5,400 shares of the company’s stock after selling 1,222 shares during the period. Stratos Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $491,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Atomi Financial Group Inc. grew its stake in Colgate-Palmolive by 12.8% in the third quarter. Atomi Financial Group Inc. now owns 6,095 shares of the company’s stock valued at $633,000 after purchasing an additional 692 shares during the last quarter. Brookstone Capital Management grew its stake in Colgate-Palmolive by 11.7% in the third quarter. Brookstone Capital Management now owns 17,366 shares of the company’s stock valued at $1,803,000 after purchasing an additional 1,814 shares during the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in Colgate-Palmolive in the third quarter valued at about $339,000. CWM LLC grew its stake in shares of Colgate-Palmolive by 28.7% during the third quarter. CWM LLC now owns 35,216 shares of the company’s stock worth $3,656,000 after acquiring an additional 7,861 shares during the last quarter. Finally, Hexagon Capital Partners LLC grew its stake in shares of Colgate-Palmolive by 9.8% during the third quarter. Hexagon Capital Partners LLC now owns 1,399 shares of the company’s stock worth $145,000 after acquiring an additional 125 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.3 %

Shares of NYSE:CL opened at $86.81 on Friday. The business’s 50 day moving average price is $90.56 and its 200-day moving average price is $96.84. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The firm has a market capitalization of $70.93 billion, a price-to-earnings ratio of 24.66, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 earnings per share. On average, equities research analysts forecast that Colgate-Palmolive will post 3.74 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.30%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CL shares. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Raymond James reiterated an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.